Technical Analysis for MDP - Medexus Pharmaceuticals Inc.

Grade Last Price % Change Price Change
C 2.150 1.90% 0.040
MDP closed up 1.9 percent on Wednesday, November 20, 2024, on 63 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Down Up

Date Alert Name Type % Chg
Calm After Storm Range Contraction 0.00%
NR7 Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Wide Bands Range Expansion 1.90%
1,2,3 Retracement Bearish Bearish Swing Setup -4.02%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -4.02%
Wide Bands Range Expansion -4.02%
Crossed Above 200 DMA Bullish 1.42%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Medexus Pharmaceuticals Inc. Description

Medexus Pharmaceuticals Inc, formerly Pediapharm Inc, is a Canada-based company engaged in pharmaceutical business sector. The Company is a North American focused, specialty pharmaceutical business that operates through three segments: Medac Pharma USA, a fully integrated commercial infrastructure focused on auto-immune diseases in the United States; Medexus Pharma Canada, a fully integrated commercial infrastructure focused on auto-immune disease and pediatric diseases in Canada; and a Business Development function, which works to maintain its product pipeline. The Company's flag products are Rasuvo and Metoject, a formulation of methotrexate (auto-pen and pre-filled syringe) designed to treat rheumatoid arthritis and other auto-immune diseases; and Rupall, an allergy medication. The Company provides products for the healthcare professionals and patients.


Classification

Keywords: Health Healthcare Infrastructure Pipe Pharma Pipeline Pharmaceutical Integrated Disease Drugs Pharmaceuticals Diseases Arthritis Medication Immunosuppressants Rheumatoid Arthritis Cnx Nifty Pharmaceutical Business Sector Pharmaceutical Industry In China

Is MDP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 3.16
52 Week Low 1.44
Average Volume 30,144
200-Day Moving Average 2.041
50-Day Moving Average 2.471
20-Day Moving Average 2.271
10-Day Moving Average 2.105
Average True Range 0.141
RSI (14) 41.86
ADX 44.76
+DI 16.092
-DI 35.206
Chandelier Exit (Long, 3 ATRs) 2.248
Chandelier Exit (Short, 3 ATRs) 2.132
Upper Bollinger Bands 2.677
Lower Bollinger Band 1.864
Percent B (%b) 0.35
BandWidth 35.789
MACD Line -0.114
MACD Signal Line -0.113
MACD Histogram -0.0011
Fundamentals Value
Market Cap 31.08 Million
Num Shares 14.5 Million
EPS -0.66
Price-to-Earnings (P/E) Ratio -3.27
Price-to-Sales 0.84
Price-to-Book 3.19
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.255
Resistance 3 (R3) 2.253 2.217 2.238
Resistance 2 (R2) 2.217 2.190 2.218 2.232
Resistance 1 (R1) 2.183 2.173 2.200 2.185 2.226
Pivot Point 2.147 2.147 2.155 2.148 2.147
Support 1 (S1) 2.113 2.120 2.130 2.115 2.074
Support 2 (S2) 2.077 2.103 2.078 2.068
Support 3 (S3) 2.043 2.077 2.063
Support 4 (S4) 2.045